Allied BioScience
Latest round
- Series C
Last raised
- May 2021
Total raised
- Undisclosed
Investors
- 1
About Allied BioScience
Founded in 2005 and headquartered in Plano, US, Allied BioScience focuses on developing advanced antimicrobial solutions. The company has undergone strategic pivots to enhance its offerings and has completed 2 deals, with the most recent deal occurring on 11 May 2021.Allied BioScience specializes in advanced antimicrobial technology focused on combating infectious diseases through innovative product development. Their core offerings include long-lasting antimicrobial coatings that actively reduce the presence of viruses and bacteria on surfaces, setting them apart from traditional disinfectants which only provide temporary protection. These coatings are designed for application in diverse environments such as healthcare facilities, educational institutions, and commercial spaces, aiming to create safer and healthier environments for end users, including patients, students, and employees. The company collaborates with various scientists, institutions, and industry leaders to ensure that their products are rigorously tested for consistent performance and effectiveness.Allied BioScience generates revenue through business-to-business transactions primarily involving direct sales to various sectors, including healthcare and education. The company engages in partnerships with institutions and industry stakeholders to distribute its antimicrobial products, creating a sustainable revenue model. These transactions often involve bulk orders of their flagship antimicrobial coatings, which are utilized in ongoing maintenance and sanitation protocols. The pricing structure is designed to accommodate different client needs, with options for customizable service agreements tailored to specific sectors, ensuring long-term partnerships and repeat business. Allied BioScience aims to enhance its marketing efforts to drive brand awareness and increase revenues, and will also grow its employee base in North Texas to support back-end operations. The expansion plans focus on targeting new markets both domestically and internationally, with specific regions outlined for growth.
Who invested in Allied BioScience
1 investor across 1 round
See all investors in Allied BioScience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
May 11, 2021
Amount
Undisclosed
Investors
Questions about Allied BioScience
Who invested in Allied BioScience?
Allied BioScience has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Allied BioScience raised?
Allied BioScience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Allied BioScience last raise money?
Allied BioScience's most recent round on record is a Series C, in May 2021.
What does Allied BioScience do?
Founded in 2005 and headquartered in Plano, US, Allied BioScience focuses on developing advanced antimicrobial solutions.
Where is Allied BioScience headquartered?
Allied BioScience is headquartered in Plano, US.
Which VCs invest in companies like Allied BioScience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Allied BioScience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Allied BioScience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.